Investor Information: 2009 Press Releases

Receive E-mail AlertsE-mail Alerts
Webcast ImageWebcast
Q4 2013 PhotoMedex, Inc. Earnings Conference Call (Replay)
03/13/14 at 11:00 a.m. ET
Q4 2013 PhotoMedex, Inc. Earnings Conference Call
Thursday, March 13, 2014 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
PhotoMedex, Inc. at RBC Capital Markets Healthcare Conference (Replay)
02/26/14 at 11:30 a.m. ET
PhotoMedex, Inc. at RBC Capital Markets Healthcare Conference
Wednesday, February 26, 2014 11:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
PhotoMedex, Inc. Signs Definitive Agreement to Acquire LCA-Vision Conference Call (Replay)
02/14/14 at 8:30 a.m. ET
PhotoMedex, Inc. Signs Definitive Agreement to Acquire LCA-Vision Conference Call
Friday, February 14, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast (please click once and allow a moment to load)
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
11/05/09PhotoMedex Appoints Christina L. Allgeier Chief Financial Officer
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Nov. 5, 2009-- PhotoMedex, Inc. (Nasdaq: PHMD) today announced that Christina L. Allgeier has been promoted to the post of Chief Financial Officer of PhotoMedex, Inc., effective November 4, 2009. Ms. Allgeier is a Certified Public Accountant with significant SEC experience and joined the Company as Corporate Controller in December 2002, when PhotoMedex acquired Surgical Laser Technologies. PhotoMe... 
Printer Friendly Version
10/27/09PhotoMedex Offers Free Seminar for Psoriasis Patients: "A Win for Your Skin in the Daily Fight Against Psoriasis"
Featuring the newest XTRAC Velocity Excimer Laser therapies MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 27, 2009-- PhotoMedex, Inc. (Nasdaq: PHMD) a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. The seminar, “A Win for Your Skin in the Daily Fight Against Psoriasis with XTRAC® Excimer Lasers,” is open to the public and w... 
Printer Friendly Version
10/26/09PhotoMedex Ranked 22nd in Deloitte's Technology Fast 50 Program for Greater Philadelphia
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 26, 2009-- PhotoMedex (Nasdaq:PHMD) has ranked number 22 on the 2009 Greater Philadelphia Fast 50, Deloitte’s ranking of the 50 fastest growing technology, life sciences and cleantech companies in the area. Rankings are based on percentage of fiscal year revenue growth during the five year period from 2004 – 2008. Dennis McGrath, PhotoMedex’s CEO said, “I am very pleased to... 
Printer Friendly Version
10/23/09PhotoMedex Raises $2.7 Million in Private Placement of Common Stock
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Oct. 23, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross proceeds from the private placement are approximately $2.7 million. The purchasers were accredited investors, some of which were institutions. No finders’ fees or warrants were involved in the placement. The Compa... 
Printer Friendly Version
09/18/09PhotoMedex Receives Notice from NASDAQ
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sep. 18, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) (the “Company”) announced today that it received notification from The Nasdaq Stock Market (“Nasdaq”) on September 15, 2009 that the Company was not in compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq’s Global Market exchange under Nasdaq Marketplace Rule 4450(a)(5) (the “Rule”). Such a... 
Printer Friendly Version
09/17/09PhotoMedex Announces New Series of Neova Educational Workshops
Expert Speakers Will Cover the Latest Advances in Clinical Skincare Such as DNA Repair, Restorative Copper Peptide Therapies and Breakthroughs in LED Aesthetic Devices MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sep. 17, 2009-- PhotoMedex, Inc. (Nasdaq: PHMD), a leading provider of advanced dermatology, clinical skincare and medical laser products, today announced that it will offer a series of four complimentary educational workshops in ... 
Printer Friendly Version
09/17/09NASDAQ Grants PhotoMedex Exception Necessary for First Tranche of Financing of Up To $6 Million
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sep. 17, 2009-- PhotoMedex, Inc. (NASDAQ: PHMD) today announced that NASDAQ has granted the Company’s request for an exception to NASDAQ’s stockholder approval requirements, in accordance with NASDAQ Listing Rule 5635. This will enable the Company to raise, in the first tranche of a private placement without stockholder approval, up to nearly $4 million in the near term through the issuance of up to ... 
Printer Friendly Version
09/15/09PhotoMedex Announces New Formula for DNA Reparation Neova(R) DNA Repair Factor Nourishing Lotion
Unique Formula Combines DNA Repair and Copper Peptides in First Combination Therapy Product on the Market MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Sep. 15, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) a leading provider of advanced dermatology, clinical skincare and medical laser products, today announced Neova® DNA Repair Factor Nourishing Lotion, the newest addition to its renowned Neova brand of skin and hair products. This breakthrough fo... 
Printer Friendly Version
07/06/09PhotoMedex Appoints New CEO
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jul. 6, 2009-- PhotoMedex, Inc. (NASDAQ:PHMD), a leader in dermatology products and techniques, announced today that Jeffrey O’Donnell, President and CEO, has resigned from the Company and the board of directors to pursue other business interests. Mr. O’Donnell has led PhotoMedex since 1999, and under his leadership the Company has grown into a portfolio of dermatology focused businesses based on ... 
Printer Friendly Version
06/01/09Introducing The Pioneering XTRAC Velocity(TM) Excimer Laser: Delivers Psoriasis And Vitiligo Treatments Three Times Faster
Breakthrough Device Can Cover a Significantly Higher Percentage of a Person's Body Surface Per Session, Providing Practical Alternative to Pharmaceuticals, Biologics or Full-Body Phototherapy MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jun. 1, 2009-- PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, today announced the availability of its groundbr... 
Printer Friendly Version
05/14/09PhotoMedex Reports First Quarter Results
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May. 14, 2009-- PhotoMedex, Inc. (NASDAQ: PHMD), a leader in dermatology products and technologies, today reported financial results for the three months ended March 31, 2009. Highlights of the 2009 first quarter include: Revenues of $7.5 million, down 10% from the prior year XTRAC® recognized procedures up 30% over the prior year and down 14% sequentially ... 
Printer Friendly Version
05/07/09PhotoMedex to Hold First Quarter 2009 Conference Call
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--May. 7, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) will hold a conference call to discuss the Company's first quarter 2009 results on Thursday, May 14, 2009 at 4:30 p.m. Eastern Time. The first quarter results will be announced on May 14th, prior to the conference call. To participate in the conference call, dial 800-432-7890 (and confirmation code # 3790427) approximately 5 to 10 minutes prior... 
Printer Friendly Version
04/21/09PhotoMedex Helps Clinics Ensure Positive Patient Experience With New XTRAC(R) Laser Post-Procedure Kit
Three-Product Kit Uses GHK Copper Peptide Complex(R) to Heal, Comfort and Protect Post-Treatment Skin MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Apr. 21, 2009-- PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, today unveiled the XTRAC® Laser Post-Procedure Kit, an exciting new three-product system that clinics can offer their patients to ... 
Printer Friendly Version
03/19/09PhotoMedex Reports 2008 Fourth Quarter and Full Year Results
Appoints John M. Glazer to Board of Directors MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Mar. 19, 2009-- PhotoMedex, Inc. (NASDAQ: PHMD) today reported financial results for the three and 12 months ended December 31, 2008. Financial highlights of the 2008 fourth quarter and year include: Revenues for the year increased 12% to $34,770,292 from the prior year, and for the quarter decreased 13% to $8,252,552 from the third quarter. Th... 
Printer Friendly Version
03/12/09PhotoMedex to Hold Fourth Quarter 2008 Conference Call
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Mar. 12, 2009-- PhotoMedex, Inc. (Nasdaq: PHMD) will hold a conference call to discuss the Company's fourth quarter 2008 results on Thursday, March 19, 2009 at 4:30 p.m. Eastern Time. The fourth quarter results will be announced on March 19th, prior to the conference call. To participate in the conference call, dial 866-288-0541 (and confirmation code # 6149844) approximately 5 to 10 m... 
Printer Friendly Version
03/11/09PhotoMedex Introduces Neova Advanced Essential Lash(TM)
Combat Thinning Lashes with Essential Copper SAN FRANCISCO--(BUSINESS WIRE)--Mar. 11, 2009-- PhotoMedex, Inc. (NASDAQ:PHMD) announced today that Procyte, a PhotoMedex company, has launched its new eyelash conditioner at the winter conference of the American Academy of Dermatology (AAD) in San Francisco this past weekend. Neova Advanced Essential Lash™, formulated with Procyte’s patented AHK Copper Peptide Complex® technology, botanicals and essentia... 
Printer Friendly Version
03/02/09PhotoMedex Completes Acquisition of Photo Therapeutics
Funding Provided by Perseus, L.L.C. MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Mar. 2, 2009-- PhotoMedex, Inc. (Nasdaq: PHMD), a leader in the development of proprietary excimer lasers and a broad range of products for other dermatological applications, today announced the closing of the acquisition of Photo Therapeutics Limited. Under the terms of the agreement the initial purchase price of $13 million was paid at closing, and up to an additional $7 mi... 
Printer Friendly Version
01/27/09PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jan. 27, 2009--PhotoMedex, Inc. (Nasdaq:PHMD) announced today the effectiveness of the reverse split of its common stock in the ratio of 1-for-7. The Company's common stock will begin trading at the market opening on January 27, 2009 on a split-adjusted basis under the symbol PHMDD for a period of 20 business days, or February 25, 2008, at which time the stock symbol will revert back to PHMD. The reverse split is inten... 
Printer Friendly Version
01/26/09PhotoMedex Announces Results of Stockholders' Meeting
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--Jan. 26, 2009--PhotoMedex, Inc. (Nasdaq:PHMD) announced the results of its 2009 Annual Stockholders' Meeting held on January 26, 2009, at the offices of Morgan, Lewis & Bockius LLP, 1701 Market Street, Philadelphia, PA 19103. The following matters were approved by the Company's stockholders: Election to the Company's Board of Directors each of Richard J. DePiano, Jeffrey F. O'Donnell, Alan R. Novak, Ant... 
Printer Friendly Version